Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-17 06:02 am Sale | 2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 1,178,503 1.900% | -3,282,190 (-73.58%) | Filing History |
| 2024-12-09 6:18 pm Sale | 2024-12-05 | 13G | Generation Bio Co. GBIO | BB Biotech AG | 3,310,869 5.000% | -297,411 (-8.24%) | Filing History |
| 2024-11-18 9:49 pm Sale | 2024-11-14 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 904,001 9.900% | -125,819 (-12.22%) | Filing History |
| 2024-11-14 8:34 pm Sale | 2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB Biotech AG | 7,850,000 5.000% | -740,000 (-8.61%) | Filing History |
| 2024-11-14 7:32 pm Sale | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 0 0.000% | -7,879,583 (Position Closed) | Filing History |
| 2024-11-14 7:21 pm Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | BB Biotech AG | 5,157,290 4.900% | 475,000 (+10.14%) | Filing History |
| 2024-11-14 6:14 pm Purchase | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 4,460,693 7.300% | 955,693 (+27.27%) | Filing History |
| 2024-04-22 8:35 pm Purchase | 2024-04-17 | 13G | Annexon, Inc. ANNX | BB Biotech AG | 4,682,290 5.200% | 4,682,290 (New Position) | Filing History |
| 2024-02-13 11:00 am Purchase | 2023-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 1,029,820 19.200% | 1,029,820 (New Position) | Filing History |
| 2024-02-13 10:13 am Unchanged | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 4,494,458 3.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 06:28 am Purchase | 2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 3,505,000 5.800% | 404,722 (+13.05%) | Filing History |
| 2024-02-13 06:17 am Unchanged | 2023-12-31 | 13G | Generation Bio Co. GBIO | BB Biotech AG | 3,608,280 5.500% | 0 (Unchanged) | Filing History |
| 2024-02-13 06:13 am Purchase | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 9,929,963 16.000% | 1,000,000 (+11.20%) | Filing History |
| 2024-02-13 06:09 am Sale | 2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB Biotech AG | 8,590,000 6.000% | -1,045,000 (-10.85%) | Filing History |
| 2024-02-13 06:07 am Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB Biotech AG | 4,000,000 7.200% | -30,792 (-0.76%) | Filing History |
| 2024-02-13 06:06 am Purchase | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | BB Biotech AG | 5,046,700 3.100% | 269,138 (+5.63%) | Filing History |
| 2024-02-13 06:05 am Purchase | 2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX | BB Biotech AG | 8,517,839 16.500% | 3,140,000 (+58.39%) | Filing History |
| 2024-02-13 06:04 am Unchanged | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 7,879,583 17.900% | 0 (Unchanged) | Filing History |
| 2024-01-24 3:46 pm Purchase | 2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 9,194,064 5.100% | 5,000,000 (+119.22%) | Filing History |
| 2024-01-24 3:21 pm Unchanged | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,194,064 3.700% | 0 (Unchanged) | Filing History |